Vitruvias Therapeutics Inc.
34 drugs in NADAC|34 Generic,0 Brand
Vitruvias Therapeutics Inc. lists 34 NDCs in the CMS NADAC file (34 generic, 0 brand), at an average NADAC of $2.48 per unit, with a week-over-week move of -1.5% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
34
34G / 0B
Avg Price / Unit
$2.4845
$0.08 – $11.46
Avg 7d Change
-1.53%
Across 30 drugs with changes
7d Activity
of 34 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Vitruvias Therapeutics Inc. make?
Vitruvias Therapeutics Inc. lists 34 NDCs in the CMS NADAC file — 34 generic and 0 brand products.
What is the average price of Vitruvias Therapeutics Inc. drugs?
The average NADAC across Vitruvias Therapeutics Inc.'s portfolio is $2.4845 per unit, ranging from $0.0779 to $11.4632.
What types of drugs does Vitruvias Therapeutics Inc. make?
Vitruvias Therapeutics Inc. makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are N-methyl-D-aspartate Receptor Antagonist (6), Vitamin B12 (6), Antifibrinolytic Agent (3), Antiarrhythmic (3), Aminoketone (3).
Has Vitruvias Therapeutics Inc. had any drug recalls?
No FDA enforcement recalls are matched to Vitruvias Therapeutics Inc. in the openFDA feed.
How has Vitruvias Therapeutics Inc.'s pricing changed recently?
Over the past 7 days, 9 Vitruvias Therapeutics Inc. products rose and 21 fell, with a portfolio-wide average change of -1.5%.